# Women's Health Sector

Canonical URL: https://biopharmsignal.com/sector/women-s-health

Women's Health is a company sector tag on BioPharmSignal. This page groups public biotech and healthcare companies associated with Women's Health, making it easier to scan related businesses, compare peers, and follow companies exposed to the same modality, disease area, or development theme.

Companies currently grouped under Women's Health: 14

## Recent Sector News

- 2026-09-03 15:17 EST — PGNY — [Progyny, Inc. to Present at the Wells Fargo Healthcare Conference](https://biopharmsignal.com/news/PGNY/progyny-inc-to-present-at-the-wells-fargo-healthcare-conference-7dac5541) — Source: Progyny
- 2026-08-26 13:00 EST — FEMY — [Femasys Partners with UNC Health to Introduce Its FemaSeed® Fertility Portfolio Across Statewide OB/GYN Care Locations](https://biopharmsignal.com/news/FEMY/femasys-partners-with-unc-health-to-introduce-its-femaseed-fertility-portfolio-a-9ab427cc) — Source: FEMASYS
- 2026-08-25 12:00 EST — SERA — [1 in 10 U.S. Babies Are Born Too Early. A Leading OB-GYN Says Most Mothers Can Learn Their Risk by Week 21, and Do Something About It](https://biopharmsignal.com/news/SERA/1-in-10-u-s-babies-are-born-too-early-a-leading-ob-gyn-says-most-mothers-can-lea-3ce74ffe) — Source: Sera Prognostics
- 2026-08-19 20:30 EST — SERA — [SERA PROGNOSTICS APPOINTS SCOTT GLEASON CHIEF FINANCIAL OFFICER](https://biopharmsignal.com/news/SERA/sera-prognostics-appoints-scott-gleason-chief-financial-officer-4701ba99) — Source: Sera Prognostics
- 2026-08-19 13:00 EST — FEMY — [Femasys Announces FDA Approval of Modular PMA Submission Approach for FemBloc®](https://biopharmsignal.com/news/FEMY/femasys-announces-fda-approval-of-modular-pma-submission-approach-for-fembloc-ca44fc30) — Source: FEMASYS
- 2026-08-14 20:05 EST — FEMY — [Femasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate Update](https://biopharmsignal.com/news/FEMY/femasys-announces-financial-results-for-quarter-ended-june-30-2026-and-provides--48093ff5) — Source: FEMASYS
- 2026-08-12 20:05 EST — SERA — [SERA PROGNOSTICS REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS](https://biopharmsignal.com/news/SERA/sera-prognostics-reports-second-quarter-2026-financial-results-4e6a97b0) — Source: Sera Prognostics
- 2026-08-12 13:00 EST — FEMY — [Femasys Strengthens and Extends Global Patent Protection for FemBloc® with First Issued Blended Polymer Patents](https://biopharmsignal.com/news/FEMY/femasys-strengthens-and-extends-global-patent-protection-for-fembloc-with-first--d1729517) — Source: FEMASYS
- 2026-08-11 20:00 EST — TXMD — [TherapeuticsMD Announces Second Quarter 2026 Financial Results](https://biopharmsignal.com/news/TXMD/therapeuticsmd-announces-second-quarter-2026-financial-results-da47e180) — Source: TherapeuticsMD
- 2026-08-07 14:51 EST — PGNY — [Progyny, Inc. to Present at the Canaccord Genuity Annual Growth Conference](https://biopharmsignal.com/news/PGNY/progyny-inc-to-present-at-the-canaccord-genuity-annual-growth-conference-b39cf730) — Source: Progyny
- 2026-08-07 13:25 EST — FEMY — [Femasys Secures $30 Million Private Placement, with Potential Proceeds of Up to $90 Million](https://biopharmsignal.com/news/FEMY/femasys-secures-30-million-private-placement-with-potential-proceeds-of-up-to-90-9edc7de9) — Source: FEMASYS
- 2026-08-06 20:01 EST — PGNY — [Progyny, Inc. Announces Second Quarter 2026 Results](https://biopharmsignal.com/news/PGNY/progyny-inc-announces-second-quarter-2026-results-ca463ac9) — Source: Progyny
- 2026-07-30 20:15 EST — COO — [CooperCompanies Announces Release Date for Third Quarter 2026](https://biopharmsignal.com/news/COO/coopercompanies-announces-release-date-for-third-quarter-2026-92c94495) — Source: The Cooper Companies
- 2026-07-29 20:05 EST — SERA — [SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF SECOND QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON AUGUST 12, 2026](https://biopharmsignal.com/news/SERA/sera-prognostics-announces-conference-call-and-webcast-of-second-quarter-fiscal--2a2c0c5a) — Source: Sera Prognostics
- 2026-07-23 19:30 EST — PGNY — [Progyny, Inc. Announces Details for Its Second Quarter 2026 Results Report](https://biopharmsignal.com/news/PGNY/progyny-inc-announces-details-for-its-second-quarter-2026-results-report-c59a2781) — Source: Progyny
- 2026-07-09 20:05 EST — SERA — [PRIME SUBGROUP ANALYSIS DEMONSTRATES 22% REDUCTION IN NICU ADMISSIONS IN FIRST-TIME PREGNANCIES USING PreTRM® Test-GUIDED CARE](https://biopharmsignal.com/news/SERA/prime-subgroup-analysis-demonstrates-22-reduction-in-nicu-admissions-in-first-ti-1eec527c) — Source: Sera Prognostics
- 2026-06-30 20:15 EST — COO — [CooperCompanies Releases 2025 Corporate Sustainability Report with Scope 3 Emissions Disclosure](https://biopharmsignal.com/news/COO/coopercompanies-releases-2025-corporate-sustainability-report-with-scope-3-emiss-7902aa71) — Source: The Cooper Companies
- 2026-06-30 20:05 EST — SERA — [SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF MARK CAPONE TO ITS BOARD OF DIRECTORS](https://biopharmsignal.com/news/SERA/sera-prognostics-announces-appointment-of-mark-capone-to-its-board-of-directors-8cc61214) — Source: Sera Prognostics
- 2026-06-24 20:05 EST — SERA — [SERA PROGNOSTICS COLLABORATES ON ARPA-H AWARD TO ADVANCE POINT-OF-CARE DIAGNOSTIC FOR SAFER BIRTH](https://biopharmsignal.com/news/SERA/sera-prognostics-collaborates-on-arpa-h-award-to-advance-point-of-care-diagnosti-7f391c59) — Source: Sera Prognostics
- 2026-06-24 13:00 EST — FEMY — [Femasys Regains Compliance with Nasdaq Listing Requirements](https://biopharmsignal.com/news/FEMY/femasys-regains-compliance-with-nasdaq-listing-requirements-6f7badb3) — Source: FEMASYS

## Companies

- [AGRX](https://biopharmsignal.com/company/AGRX) — Agile Therapeutics
- [AWH](https://biopharmsignal.com/company/AWH) — Aspira Women's Health
- [DARE](https://biopharmsignal.com/company/DARE) — Dare Bioscience, Inc.
- [EVFM](https://biopharmsignal.com/company/EVFM) — Evofem Biosciences
- [FEMY](https://biopharmsignal.com/company/FEMY) — FEMASYS
- [HOLX](https://biopharmsignal.com/company/HOLX) — Hologic
- [IVOB](https://biopharmsignal.com/company/IVOB) — INVO BioScience
- [UTRS](https://biopharmsignal.com/company/UTRS) — Minerva Surgical
- [NTRA](https://biopharmsignal.com/company/NTRA) — Natera
- [OBSV](https://biopharmsignal.com/company/OBSV) — ObsEva
- [PGNY](https://biopharmsignal.com/company/PGNY) — Progyny
- [SERA](https://biopharmsignal.com/company/SERA) — Sera Prognostics
- [COO](https://biopharmsignal.com/company/COO) — The Cooper Companies
- [TXMD](https://biopharmsignal.com/company/TXMD) — TherapeuticsMD